Sanofi (SNY) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to $0.26.
- Sanofi's Debt to Equity rose 2614.71% to $0.26 in Q4 2025 from the same period last year, while for Dec 2025 it was $0.26, marking a year-over-year increase of 2614.71%. This contributed to the annual value of $0.26 for FY2025, which is 2614.71% up from last year.
- As of Q4 2025, Sanofi's Debt to Equity stood at $0.26, which was up 2614.71% from $0.29 recorded in Q2 2025.
- Over the past 5 years, Sanofi's Debt to Equity peaked at $7.99 during Q2 2021, and registered a low of $0.21 during Q4 2024.
- Moreover, its 5-year median value for Debt to Equity was $0.26 (2023), whereas its average is $1.03.
- Per our database at Business Quant, Sanofi's Debt to Equity soared by 203831.05% in 2021 and then tumbled by 9666.57% in 2022.
- Sanofi's Debt to Equity (Quarter) stood at $0.3 in 2021, then dropped by 13.93% to $0.25 in 2022, then decreased by 13.37% to $0.22 in 2023, then decreased by 6.78% to $0.21 in 2024, then increased by 26.15% to $0.26 in 2025.
- Its last three reported values are $0.26 in Q4 2025, $0.29 for Q2 2025, and $0.21 during Q4 2024.